Article Versions Notes

Kogue Y, Kobayashi H, Nakamura Y, Takano T, Furuta C, Kawano O, Yasuma T, Nishimura T, D’Alessandro-Gabazza CN, Fujimoto H, et al. Prognostic Value of CXCL12 in Non-Small Cell Lung Cancer Patients Undergoing Tumor Resection. Pharmaceuticals. 2023; 16(2):255. https://doi.org/10.3390/ph16020255

Kogue, Yurie, Hiroyasu Kobayashi, Yutaka Nakamura, Takatsugu Takano, Chihiro Furuta, Osamu Kawano, Taro Yasuma, Tadashi Nishimura, Corina N. D’Alessandro-Gabazza, Hajime Fujimoto, and et al. 2023. "Prognostic Value of CXCL12 in Non-Small Cell Lung Cancer Patients Undergoing Tumor Resection" Pharmaceuticals 16, no. 2: 255. https://doi.org/10.3390/ph16020255

Kogue, Y., Kobayashi, H., Nakamura, Y., Takano, T., Furuta, C., Kawano, O., Yasuma, T., Nishimura, T., D’Alessandro-Gabazza, C. N., Fujimoto, H., Gabazza, E. C., Kobayashi, T., & Fukai, I. (2023). Prognostic Value of CXCL12 in Non-Small Cell Lung Cancer Patients Undergoing Tumor Resection. Pharmaceuticals, 16(2), 255. https://doi.org/10.3390/ph16020255